NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis $7.41 0.00 (0.00%) Closing price 06/5/2026 04:00 PM EasternExtended Trading$7.62 +0.21 (+2.87%) As of 06/5/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LifeStance Health Group Stock (NASDAQ:LFST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LFST alerts:Sign Up Key Stats Today's Range$7.36▼$7.6450-Day Range$6.24▼$8.8552-Week Range$3.74▼$8.89Volume1.86 million shsAverage Volume3.67 million shsMarket Capitalization$2.87 billionP/E Ratio123.50Dividend YieldN/APrice Target$9.75Consensus RatingModerate Buy Company Overview LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans. The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations. LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services. AI Generated. May Contain Errors. Read More LifeStance Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreLFST MarketRank™: LifeStance Health Group scored higher than 87% of companies evaluated by MarketBeat, and ranked 73rd out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingLifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.91, and is based on 2 strong buy ratings, 6 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialLifeStance Health Group has a consensus price target of $9.75, representing about 31.6% upside from its current price of $7.41.Amount of Analyst CoverageLifeStance Health Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LifeStance Health Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth75.00% Earnings GrowthEarnings for LifeStance Health Group are expected to grow by 75.00% in the coming year, from $0.12 to $0.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is 123.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.53.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is 123.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.09.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.29% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 1.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 24.34%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.66 News SentimentLifeStance Health Group has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for LifeStance Health Group this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $55,048,226.00 in company stock.Percentage Held by Insiders6.60% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFST Stock News HeadlinesLifestance Shareholders Reaffirm Board, Auditor and Executive PayJune 4, 2026 | tipranks.comLifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Recommendation of "Buy" by AnalystsJune 3, 2026 | americanbankingnews.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. | Porter & Company (Ad)Assessing LifeStance Health Group (LFST) Valuation After Recent Share Price MomentumJune 2, 2026 | finance.yahoo.comEric Shuey Sells 243,362 Shares of LifeStance Health Group (NASDAQ:LFST) StockMay 15, 2026 | insidertrades.comBarclays Sticks to Its Buy Rating for Lifestance Health Group (LFST)May 14, 2026 | theglobeandmail.comLifeStance Health Group, Inc. (LFST) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptMay 13, 2026 | seekingalpha.comLifeStance executes secondary offering and share repurchaseMay 12, 2026 | tipranks.comSee More Headlines LFST Stock Analysis - Frequently Asked Questions How have LFST shares performed this year? LifeStance Health Group's stock was trading at $7.04 at the start of the year. Since then, LFST shares have increased by 5.3% and is now trading at $7.41. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) issued its quarterly earnings data on Wednesday, May, 6th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.03. The business's quarterly revenue was up 21.2% compared to the same quarter last year. Read the conference call transcript. Is LifeStance Health Group doing a stock buyback? LifeStance Health Group's board approved a share repurchase plan on Wednesday, February 25th 2026, which permits the company to buy back $100,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's board believes its stock is undervalued. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an IPO on Wednesday, June 9th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's top institutional shareholders include Dimensional Fund Advisors LP (2.67%), Jennison Associates LLC (2.64%), Silversmith Partners I GP LLC (1.59%) and Principal Financial Group Inc. (0.79%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Eric Shuey, Ryan Pardo, Danish J Qureshi, David Bourdon, Ann Varanakis, Anisha Patel-Dunn, Lisa K Miller, Paula Cipollone and Ujjwal Ramtekkar. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeStance Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/06/2026Today6/08/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (9m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 LFST's financial health is in the Green zone, according to TradeSmith. LFST has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:LFST CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees10,961Year Founded2017Price Target and Rating Average Price Target for LifeStance Health Group$9.75 High Price Target$12.00 Low Price Target$8.00 Potential Upside/Downside+31.6%Consensus RatingModerate Buy Rating Score (0-4)2.91 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio123.50 Forward P/E Ratio61.75 P/E GrowthN/ANet Income$9.66 million Net Margins1.55% Pretax Margin2.25% Return on Equity1.56% Return on Assets1.07% Debt Debt-to-Equity Ratio0.18 Current Ratio1.48 Quick Ratio1.48 Sales & Book Value Annual Sales$1.42 billion Price / Sales2.02 Cash Flow$0.17 per share Price / Cash Flow44.05 Book Value$3.91 per share Price / Book1.90Miscellaneous Outstanding Shares387,830,000Free Float362,237,000Market Cap$2.87 billion OptionableOptionable Beta1.19 Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:LFST) was last updated on 6/8/2026 by MarketBeat.com Staff. From Our PartnersThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIn 30 days, you'll wish you'd read this emailA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTiny Nasdaq Firm Lands €13.9 Million Semiconductor DealOne small Nasdaq-listed company just landed a 13.9 million euro contract tied to a new advanced-node semicondu...Finplays | SponsoredAmerica's AI Future Needs a Domestic Fuel ChainAI dominance requires power at a scale most investors have not priced in - and nuclear energy is emerging as a...i2i Marketing Group, LLC | SponsoredHow to get into the SpaceX IPO before June 12Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
